Friday, 05 June 2020

Project List

Cohort Event Monitoring of Artemisinin combination therapies (ACTs)

Malaria is a leading cause of mortality and morbidity in Zimbabwe. Due to the increase in cases of resistance to anti-malarials such as chloroquine, the World Health Organisation (WHO) and the Ministry of Health and Child Welfare (of Zimbabwe) is now promoting the use of artemisinin combination therapies (ACTs) for the treatment of uncomplicated acute falciparum malaria. Although ACTs are known to be safe and effective, their safety under large-scale operational use has not been fully assessed particularly among children and pregnant women. This project aims to assess the safety of ACTs among the Zimbabwean population.

Cohort Event Monitoring is a method where information is collected, with focus on events, an all patients in a group being treated with a medicine or group of medicines. The cohort is selected without bias from all patients being treated with the monitored medicine, and the events include also incidents, not only adverse drug reactions (ADRs)

The specific objectives of this project are to:

  •  Detect signals of unrecognised reactions.
  • Identify interactions with other medicines, complementary and alternative medicines and foods
  • Identify risk factors so that they can be avoided.
  • Assess the safety of ACTs in pregnancy and lactation
  • Provide evidence for effective risk management i.e benefit/harm assessment.

Future projects:

  • Cohort Event Monitoring of Anti-tubercle and antiretroviral medicines in the public sector in Zimbabwe.
  • Post-market surveillance of antiretroviral and anti-tubercle medicines in Zimbabwe.


Latest News

Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

06 April 2020
Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

  This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19.   Medical...

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...